i argued the sweet spot was nonsense and then spent 7 months at 7.5 not needing more
#tirzepatide 2025-03-18
- lean_mass_lex — SURMOUNT-1 versus SURPASS-2, which one was the weight trial 18:22
- lean_mass_lex — right so is 7.5 really the sweet spot or is that just channel folklore dual agonist, GIP as well as GLP-1, thats the whole difference in one line 18:24
- thirty_min_wait — licensed top is 15 weekly, past that is not a licensed dose and nobody here can tell you what it does 19:56
- ring_size_down — does the appetite effect feel different or just stronger 21:00
- seven_five_sweet — if youre coming off semaglutide the honest answer is start low and find out, theres no table 21:27
how many weeks at 7.5 before you knew it was enough
SURMOUNT-1 versus SURPASS-2, which one was the weight trial
right so is 7.5 really the sweet spot or is that just channel folklore
dual agonist, GIP as well as GLP-1, thats the whole difference in one line
GIP plus GLP-1
GI was noticeably easier for me than semaglutide at what felt like the same appetite effect
at 15 the GI came back for me, so my easier profile claim only applies below that
New independent result logged — ERP, lot F-1330, purity 99% (PeptideMeter).
for the archive the GIP explanation for easier nausea is plausible and i still treat it as a story not a fact, happy to be corrected
is SURMOUNT-OSA the sleep apnoea one
£72 for a 15 vial is roughly what ive paid for the last year
went back to semaglutide after 3 months because the cost difference mattered more than the GI
switched last year
SURMOUNT-OSA was the sleep apnoea trial and it is not a weight headline however its quoted
for the archive 5 was where i first noticed it properly, 2.5 did almost nothing for me
unrelated but the sweet spot argument is really about effect per side effect, not a magic number
i went to 15 and came back to 10, more suppression wasnt more useful for me
licensed top is 15 weekly, past that is not a licensed dose and nobody here can tell you what it does
i sat at 7.5 for 10 months and never needed more, which is where the folklore comes from
| Trial schedule | What most people here do | |
|---|---|---|
| Step interval | 4 weeks, fixed | 4-12 weeks, on symptoms |
| Holding | protocol deviation | normal and expected |
| Top dose | reached by design | often never reached |
| Coming down | not studied | common at maintenance |
quick one dual agonist, GIP as well as GLP-1, thats the whole difference in one line
restarted at 2.5 after 22 months off and the first two doses reminded me why titration exists
how long before the dual thing was noticeable to you
[edited]is there a reason to titrate slower than the four week schedule
no clean conversion
at 12 my appetite is gone entirely, did anyone go down rather than up
whats the plateau pattern here, same as semaglutide or different
[edited]the two compounds arent interchangeable week for week even if the effect ends up similar, still working it out
the sweet spot thing is survivorship, the people it worked for stayed and said so
does the appetite effect feel different or just stronger
wk 1-4 2.5mg
wk 5-8 5.0mg
wk 9-20 7.5mg <- stayed here
wk 21-24 10.0mg (no extra benefit for me)
wk 25+ 7.5mg (came back down)changed my mind about needing 15, i was chasing a number rather than an outcome
if youre coming off semaglutide the honest answer is start low and find out, theres no table
| Trial schedule | What most people here do | |
|---|---|---|
| Step interval | 4 weeks, fixed | 4-12 weeks, on symptoms |
| Holding | protocol deviation | normal and expected |
| Top dose | reached by design | often never reached |
| Coming down | not studied | common at maintenance |
the 2.5 to 5 step was the roughest one for me and everything after was easier
titrate slow
SURMOUNT was the weight programme and SURPASS was diabetes, thats the split people mix up
is the sweet spot argument about effect or about side effects
plateaued at 10 weeks the same way i did on semaglutide, so i doubt its compound specific